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Abstract
Background: Aldehyde dehydrogenases (ALDHs) play a major role in detoxification of aldehydes. High expression
of ALDHs is a marker for stem cells of many organs including the lungs. A common polymorphism in ALDH2 gene
(ALDH2*2) results in inactivation of the enzyme and is associated with alcohol flushing syndrome and increased risk
for cardiovascular and Alzheimer’s diseases and some cancers. The effect of this ALDH2 polymorphism on the lung
and its stem cells has not been thoroughly examined.
Methods: We examined the association between the ALDH2*2 allele and lung function parameters in a population
of healthy individuals. We also examined its association with the incidence of asthma and COPD in patient cohorts.
We used the in vitro colony forming assay to detect the effect of the polymorphism on lung epithelial stem cells
from both primary human surgical samples and Aldh2*2 transgenic (Tg) and Aldh2−/− mice. Response to acute and
chronic lung injuries was compared between wild type (WT), Aldh2*2 Tg and Aldh2−/− mice.
Results: In humans, the ALDH2*2 allele was associated with lower FEV1/FVC in the general population, but not with
the development of asthma or COPD. Both the bronchial and lung epithelium carrying the ALDH2*2 allele showed
a tendency for lower colony forming efficiency (CFE) compared to ALDH2 allele. In mice, the tracheal epithelial
thickness, nuclear density, and number of basal stem cells were significantly lower in Aldh2−/− and Aldh2*2 Tg adult
mice than in WT. Electron microscopy showed significantly increased number of morphologically abnormal
mitochondria in the trachea of Aldh2−/− mice. Aldh2−/− tracheal and lung cells showed higher ROS levels and
fewer functional mitochondria than those from WT mice. No significant differences were detected when tracheal
and lung epithelial stem cells were examined for their in vitro CFE. When exposed to chronic cigarette smoke,
Aldh2*2 Tg mice were resistant to emphysema development, whereas influenza infection caused more epithelial
damage in Aldh2−/− mice than in WT mice.
Conclusions: ALDH2 polymorphism has several subtle effects on the lungs, some of which are similar to changes
observed during normal aging, suggesting a “premature lung aging” effect.
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Background
All organs and tissues in the body are continuously
exposed to locally produced endogenous oxidants and
aldehydes [1, 2]. Oxidants are generated during normal
physiological processes and are reactive intermediates
capable of damaging cellular components [1]. Aldehydes
are the major end products of lipid peroxidation and can
associate with proteins and nucleic acids to generate
adducts, known to exert various harmful effects [2].
Luckily, most cells produce antioxidants and aldehyde
dehydrogenases (ALDHs), enabling them to keep these
harmful products under control and minimize their
deleterious effects [3, 4]. Human lung, however, is addi-
tionally exposed to exogenous sources of oxidants and
aldehydes from air pollution and cigarette smoke (CS).
These factors seem to overwhelm lung defenses as alde-
hydes and oxidants in CS induce various harmful effects,
including airway inflammation, cellular injury, DNA
damage, and cytotoxicity [5–7]. High levels of ALDHs
are observed in stem cells of many tissues and organs
[8], including the proximal airways [9, 10]. The increased
levels are considered to offer additional protection to
stem cells against aldehydes. ALDH2 is one of the highest
expressed ALDHs in the airways [9, 10]. ALDH2 concen-
tration is prominently elevated in the bronchoalveolar
lavage fluid of patients with chronic obstructive pulmon-
ary disease (COPD) [11]. The main substrate of ALDH2 is
acetaldehyde, an intermediary product during ethanol me-
tabolism. It functions mainly in the mitochondria, which
are also an important source of reactive oxygen species
(ROS). Furthermore, ALDH2 seems to function as an
antioxidant as its overexpression provides protection
from oxidative stress, while its deficiency augments
the stress [12, 13].
A single nucleotide polymorphism in ALDH2 (termed
ALDH2*2), rs671, results in the amino acid change
Glu478Lys. This mutant allele has a dominant-negative
effect, resulting in the complete or near-complete loss of
ALDH2 enzymatic activity in individuals who are homo-
zygous or heterozygous for the ALDH2*2 allele [14].
This polymorphism is very common in East Asians and
affects almost half of the population [14]. Epidemio-
logical and functional studies found that the ALDH2*2
allele is associated with facial flushing and increased
pulse rate upon alcohol consumption [15], increased risk
for cardiovascular diseases [16], late-onset Alzheimer’s
disease [17], osteoporosis [18], and several alcohol-
related cancers, including oropharyngolaryngeal, esopha-
geal, stomach, and colon cancers [19].
However, despite distinctive lung exposure to both en-
dogenous as well as exogenous aldehydes and oxidants,
the effects of loss of ALDH2 function on the lungs of in-
dividuals with the ALDH2*2 polymorphism have not
been studied extensively.
In this study, we extensively examined the effect of
ALDH2 functional disturbance on lung histology and
function in both humans and mice using in vitro and in
vivo studies as well as a human genetic association
study.
Methods
Human subjects for the genetic association study
To detect the overall effect of the ALDH2 polymorphism
on lung function in the general population, we con-
ducted a cross-sectional association study on healthy
volunteers (n = 967). Longitudinal data were also
assessed for the annual decline of forced expiratory
volume in 1 s (FEV1) over at least four years (n = 742).
Additionally, to identify if the mutant allele is associated
with the incidence of bronchial asthma or COPD, we
genotyped a cohort of patients with bronchial asthma
(n = 751) and COPD (n = 289) in comparison to the
general population. Patients with bronchial asthma and
COPD were recruited from the Tsukuba University
Hospital and its affiliated hospitals [20–22]. Recruit-
ment of the healthy volunteers was carried out as de-
scribed previously [23]. They were recruited from the
general population who visited the hospital for annual
health checkups. Individuals with no evidence of pul-
monary disease were included as healthy volunteers.
Genomic DNA was extracted from the peripheral blood
samples of all participants by an automated DNA ex-
traction system (QuickGene-610 L; Fujifilm, Tokyo,
Japan). Genotyping of patients with bronchial asthma
and COPD was carried out by using the TaqMan Drug
Metabolism Genotyping Assays. Genotyping of healthy
volunteers was carried out by using the Illumina Human-
Hap550v3 BeadChip assay (Illumina, San Diego, CA,
USA) and the genotyping data of ALDH2*2 (rs671) was
extracted using PLINK version 1.07 [23, 24]. Associations
of the ALDH2*2 genotype with lung function data in
healthy volunteers were analyzed by linear regression
models and were adjusted for age, sex and smoking status
in PLINK version 1.07. Chi-square tests were used to
analyze the association between the ALDH2*2 genotype
and the development of asthma and COPD.
Collection of epithelial cells from human lung and
bronchial samples
Human surgical samples were collected from patients with
a lung pathology that was clinically indicated for surgical
removal. Fifteen samples were from a “lobectomy”, three
were from a “pneumonectomy”, and six were from a “lung
segment” removal. An apparently healthy lung portion
away from the tumor and a portion from the bronchial
stump were excised, shipped overnight on ice and were
processed immediately upon receipt.
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Small portions were used for DNA and RNA extrac-
tion, and for paraffin embedding for histological assess-
ment. The remaining tissues were used for epithelial cell
retrieval. The lung tissue was finely minced and incu-
bated at 37 °C in 10 U/mL elastase (Porcine Pancreatic,
Elastin Products Company, Owensville, MO, USA) for
30 min. The suspension was passed through an 18G
needle using a large syringe to help disperse the tissue
pieces into single cells. The cell suspension was then
filtered through a 100-μm strainer to remove the un-
digested clumps. RBCs were depleted by adding 4 mL of
ACK lysis buffer. Up to 500 μL of DNase (Sigma
Aldrich, St. Louis, MO, USA) was added to the cell pel-
let. Then cells were incubated in 0.25% trypsin/EDTA at
37 °C for 20 min to obtain a single cell suspension.
Hematopoietic and endothelial cells were then depleted
using anti-human CD45 and CD31 microbeads on the
autoMACS cell separation system (Miltenyi Biotec,
Cologne, Germany). The cells were stained with an
anti-human EpCAM antibody (BD Biosciences, Franklin
Lakes, NJ, USA) and the epithelial cells were sorted on a
MoFlo sorter. Non-epithelial cells were plated on plastic
flasks in DMEM for 2 h to isolate the fibroblasts.
Unattached cells were discarded and the fibroblasts were
allowed to proliferate to >90% confluence, and were then
frozen for future use in co-cultures.
The portions from bronchi were cleaned under a dis-
secting microscope and were cut open, followed by incu-
bation in 50 U/mL dispase for 2 h at room temperature.
Detached epithelial sheets were scrubbed off the inner
surface and were incubated in 0.25% trypsin/EDTA at
37 °C for 30 min to obtain a single cell suspension.
These cells were then referred to as primary human
bronchial epithelial cells (HBECs), and cultured as such
or stained for a basal cell marker (ITGA6, NGFR, or
CD44) followed by sorting for basal cells.
In vitro 3D human organoid culture experiments
Bronchial epithelial cells were resuspended in MTEC/
Plus medium and were mixed 2:1 with growth factor-
reduced Matrigel (BD Biosciences). Lung cells were co-
cultured with human lung fibroblasts in transwell inserts
as previously described [9, 10].
Some culture wells were treated with the ALDH2 activa-
tor, Alda-1 [25] (Merck Millipore, Darmstadt, Germany),
at 100–300 μM and/or H2O2 at 300–400 μM as a source
of ROS. The growing colonies were imaged and were visu-
ally counted on day 14 and/or 21. Colonies in the inserts
were either embedded in Histogel (Thermo Scientific,
Waltham, MA, USA) followed by paraffin for histological
assessment, or were digested with dispase and trypsin to
single cells. Single cells were either passaged or were used
for RNA extraction.
Genotyping of human surgical samples was con-
ducted using 2 sets of PCR primers with DNA isolated
from patient lung samples as previously described [26].
Genotypes were further confirmed by the TaqMan®
genotyping assay (TaqMan Drug Metabolism Genotyping
Assays -ALDH2, Drug Metabolism Genotyping Assay mix,
Life Technologies Corporation, Waltham, MA, USA).
qRT-PCR
mRNA expression of other lung-expressed ALDHs and
several antioxidant genes was assessed by qRT-PCR. The
following primers were used on a Step-One ABI cycler
using SYBR green.
ALDH1A1: 5′-TGGCTGATTTAATCGAAAGAGAT-3′,
5′-TCCACCATTCATTGACTCCA-3′,
ALDH3A1: 5′-GGGAAGCAGGGTCCTTAAAT-3′,
5′-CGCTGATCTTGCTCATGG-3′,
HMOX-1: 5′-GGCAGAGGGTGATAGAAGAGG-3′,
5′-AGCTCCTGCAACTCCTCAAA-3′,
PRDX1: 5′-AGGCCTTCCAGTTCACTGAC-3′,
5′-CAGGCTTGATGGTATCACTGC-3′,
NQO1: 5′-CAGCTCACCGAGAGCCTAGT-3′,
5′-GAGTGAG CCAGTACGATCAGTG-3′,
NRF2: 5′-GCGACGGAAAGAGTATGAC-3′,
5′-GTTGGCAGATCCACTGGTTT-3′,
GAPDH: 5′- GAGTCAACGGATTTGGTCGT-3′,
5′-TTGATTTTGGAGGGATCTCG-3′.
Gene expression was expressed as ratios to GAPDH.
Western blotting
Small pieces of human lung samples were homogenized
and lysed with cell lysis buffer and followed by measure-
ment of protein concentrations. Equal amounts of pro-
tein were fractionated by electrophoresis and then
transferred to PVDF membranes. The membranes were
then incubated with antibodies against NRF2 (Santa
Cruz), ALDH1A1 (Abcam), and ALDH3A1 (Santa Cruz)
followed by incubation with secondary antibodies. For
the detection of specific protein bands, the membranes
were incubated in LumiGLO reagent and peroxide
(Cell Signaling Technologies, Danvers, MA, USA), and
then exposed to X-ray films.
Animals
We used two different types of mice with disturbed
ALDH2 function; Aldh2*2 transgenic (Tg) mice were
generated by the pronuclear injection of a plasmid carrying
mouse Aldh2*2 cDNA with a single nucleotide mutation
at the same position as that of the human ALDH2*2 poly-
morphism, under the control of CAG promoter [27] and
Aldh2−/− mice, in which the endogenous Aldh2 gene is re-
placed by the neomycin-resistance gene [28]. The wild type
(WT) littermates were used as controls. Trachea and lung
paraffin sections from WT, Aldh2*2 Tg, and Aldh2−/− mice
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were collected from newborn, adult, and aged mice and
stained with hematoxylin and eosin (H&E). Tracheas were
examined for epithelial thickness at 3 different locations.
Because of natural variation in epithelial thickness between
tracheal non-cartilaginous posterior portion and the rest of
the circumference, and between uppermost and lowermost
parts, we restricted our measurements and comparisons to
the supracartilaginous regions of the sides of tracheal por-
tion between cartilaginous rings 4 and 8. Four to six mice
were analyzed per group. Nuclear densities were calculated
by counting number of nuclei per a 100 μm. Quantification
for percentage of cellular types in all groups was performed
by counting from immunostained sections.
Immunostaining
Human surgical samples and mice samples were fixed
with 4% paraformaldehyde and embedded in paraffin.
Tissue sections (6-μm thickness) were prepared and im-
munostained as described previously [29]. The primary
antibodies used included rabbit K5 (Covance, Princeton,
NJ, USA), goat CC10 (SCGB1A1) and Pro-surfactant
protein C (SPC) (Santa Cruz Biotechnology), TTF1
(Abcam), mouse MUC5AC (Thermo Scientific), and
mouse acetylated β-tubulin (Sigma) for the identification
of basal, club (Clara), alveolar type II, goblet, and ciliated
cells. Interleukin (IL)-1β (Abcam), Gr-1 (BD), Peroxire-
doxin 1 (Prdx1) (Abcam) and Hemagglutinin (Abcam)
were used for characterization of the injury models. The
appropriate Alexa-Fluor coupled secondary antibodies
were used in double and triple stained sections. The
nuclei were stained with DAPI and the slides were then
examined by fluorescence microscopy using a Zeiss
AxioImager microscope (Carl Zeiss).
Transmission electron microscopy (TEM)
Tracheas were cut between the 5th and 8th tracheal
cartilaginous rings. All samples were fixed in 2.5% glu-
taraldehyde/0.1 M phosphate buffer (pH 7.4) for 2–4 h.
After post-fixation in 1.5% osmium tetroxide/ 0.1 M
phosphate buffer (pH 7.4) for 1 h, the samples were
dehydrated in ethanol, treated with propylene oxide,
then embedded in an epon resin, which was polymerized
at 60 °C for 2–3 days. Semi-thin sections were stained
with toluidine blue to select an optimal area of the epi-
thelium with straight basement membrane and without
artifacts. Ultra-thin sections were mounted on a nickel
mesh and were electron-stained with uranyl acetate and
lead citrate. The sections were then examined under a
transmission EM, JEM 1400 (JEOE, Tokyo, Japan).
Mitochondrial functional assessments
1-Extracellular flux bioenergetics assay
Mouse tracheal epithelial cells (MTEC) were collected
from at least 4 Aldh2−/− and WT mice. As this assay
requires cells to be attached, extracellular flux 24-well
culture plates (Seahorse Bioscience) were coated with
50 μg/mL collagen (BD Biosciences). These were then
seeded in triplicates with 120,000 cell/well and were in-
cubated for 2 days at 37 °C. The Oxygen Consumption
Rate (OCR) and Extracellular Acidification Rate (ECAR)
were measured in all wells according to the manufac-
turer’s instructions (Seahorse Bioscience) and as de-
scribed previously [9, 30].
2-Examination of mitochondrial inner membrane protein
The mitochondrial membrane protein Tim23 (Santa
Cruz Biotechnology) was examined by immunostaining
of histological sections from mouse lung and tracheal
tissues and in vitro colonies.
3-Measurment of ATP production
Using the CellTiter-Glo® Luminescent Cell Viability
Assay (Promega, Fitchburg, WI, USA) in an opaque-
walled 96 well plate, triplicate wells of serum-containing
culture medium without cells, and a gradient of cell
numbers from the lung and tracheal epithelium from
the different mice were tested: 1000, 5000, 25,000,
50,000, and 100,000 cells in 100 μL vol according to the
manufacturer’s protocol. Luminescence was recorded on
a plate reader at 490 nm.
4-Quantification of functional mitochondria
MitoTracker® Red FM and/or MitoTracker® Red
CMXRos (Promega) were used according to the manu-
facturer’s protocol. MTECs and lung cells were collected
from WT, Aldh2*2 Tg, and Aldh2−/− mice. From each
sample, 150,000 cells were stained in suspension, either
examined by flow cytometry or cytospun, and examined
by fluorescence microscopy.
5-Quantification of mitochondrial ROS levels
MitoSOX Red (Promega) was used according to the manu-
facturer’s protocol and 150,000 cells were stained and ex-
amined by flow cytometry or fluorescence microscopy.
The cells that were used for fluorescence microscopy
analysis were cytospun onto glass slides. The cells were
fixed by dispensing 100 μL of acetone onto the slide and
allowed to air-dry. DAPI was then added to the cells.
The cells were covered with a cover slip.
In vitro 3D mouse organoid culture experiments
Collection of MTEC and whole lung epithelium, isola-
tion of lung fibroblasts and their co-culture in Matrigel
were essentially performed as described previously [29].
The medium used, treatment with H2O2 and/or Alda-1,
quantification and processing of colonies at the end
point were performed in a manner similar to the human
organoid culture described above.
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In vivo injury models
1-Chronic injury with CS
Ten adult Aldh2*2 Tg mice and their WT littermates
were exposed to mainstream CS using commercially
available cigarettes (Marlboro, 12 mg tar/1.0 mg nico-
tine) as previously described [31]. Exposure to 4% CS
was given for one hour/day and 5 days/week for
16 weeks. Age-matched control mice for each group
were exposed to air over the same period. Emphysema
was assessed in the living animals by micro CT and after
euthanasia on the histological sections, and was quanti-
fied using mean linear intercepts (Lm) [31].
2-Acute injury with H1N1 influenza and polidocanol
Eight WT mice and seven Aldh2−/− mice were infected
through the nose with a sub-lethal dose of influenza H1N1
PR8 (100 pfu/50 μL). Survival and body weight were re-
corded daily. The lungs were collected on day 8, embedded
in paraffin, and the sections were stained with H&E and
immunostained for epithelial and hematopoietic (inflam-
matory) cell markers like SPC, CC10, β-tubulin, and CD45.
Viral load was assessed by staining for hemagglutinin.
Polidocanol has been previously used to induce acute
injury of the airway epithelium. Ten microliters of 2%
polidocanol were administered to mice anesthetized with
ketamine/xylazine [32]. However, in our hands, this
dosing strategy resulted in more than 50% mortality.
Thus, we performed preliminary experiments to
optimize the administration technique. We optimized
the route of administration (intra-nasal, intra-tracheal
via oral intubation or through a neck incision), the de-
vice used for polidocanol delivery (insulin syringe or
micro-sprayer), the volume of polidocanol (10, 15, and
20 μL), the concentration of polidocanol (0.5, 1, and
2%), the mode of anesthesia (ketamine i.p., isoflurane
inhalation, combination of ketamine i.p. and isoflurane
inhalation, isoflurane inhalation with continuous O2),
and the time points for sample collection (12 h, 24 h,
48 h, 5 days, and 7 days).
Statistics
Data from all samples from each group are expressed as
mean ± SD. The quantification of CFE and cell types was
performed by visual counting under a microscope and
digital images from at least 3 triplicates and 3 independent
experiments. T test was used for pairwise comparisons
and a P value less than 0.05 was considered significant.
Results
Japanese individuals with the ALDH2*2 genotype have
lower lung function parameters
Healthy volunteers (n = 967) were genotyped for the
ALDH2 polymorphism then were compared for their
lung function parameters based on their genotype. The
longitudinal data for the annual decline of forced expira-
tory volume in 1 s (FEV1) over at least four years were
available from 742 individuals. The incidence of the
ALDH2 polymorphism was also studied in bronchial
asthma (n = 751) and COPD (n = 289) patient cohorts in
comparison to the general population. The frequency of
the ALDH2*2 allele in these three populations ranged
between 41.1–44.8%, consistent with previous reports
for the Japanese population and in keeping with the
Hardy–Weinberg equilibrium. The clinical characteris-
tics of all participants are shown in Table 1.
The presence of an ALDH2*2 allele A is associated
with a significantly lower FEV1/FVC than that of the
WT ALDH2 allele G within the group of healthy indi-
viduals (GG vs. GA vs. AA, β = −0.621, p = 0.0164).
However, the presence of the ALDH2*2 allele A was
not associated with predicted FEV1% (GG vs. GA vs.
AA, β = −0. 424, p = 0.486) or the rate of annual FEV1
Table 1 Characteristics of healthy human participants, asthmatic and COPD patients
Healthy volunteers
(n = 967)
Bronchial asthma
(n = 751)
COPD
(n = 289)
Age (years) 50.0 ± 9.1 57.0 ± 16.8 74.7 ± 8.6
Female (%) 526 (54.4%) 445 (59.3%) 31 (10.6%)
Smoking Index Groupa, b
0
607 (62.8%) 481 (64.0%) 10 (3.5%)
1–200 126 (13.0%) 103 (13.7%) 9 (3.1%)
>200 234 (24.2%) 145 (19.3%) 269 (93.1%)
FVC (L) 3.22 ± 0.76 2.92 ± 0.94 2.65 ± 0.87
FEV1 (L) 2.68 ± 0.64 2.11 ± 1.06 1.25 ± 0.58
Predicted FEV1 (%) 93.3 ± 12.1 85.3 ± 22.7 53.4 ± 22.1
FEV1/FVC (%) 83.2 ± 5.2 71.0 ± 12.4 47.2 ± 12.4
FEV1 decline (mL/year) 23.4 ± 49.3 (n = 742) NA NA
aThe Smoking Index Group is calculated by multiplying the average number of cigarettes smoked per day with the number of years of smoking
bSmoking history was not available for 22 and 1 asthma and COPD patients, respectively
Kuroda et al. Respiratory Research  (2017) 18:69 Page 5 of 18
decline over the examined period of 4 years (GG vs.
GA vs. AA, β = −1.122, p = 0.496). Additionally, the
ALDH2*2 allele was not associated with the develop-
ment of bronchial asthma or COPD (p = 0.42 and
0.747, respectively).
Histological and functional assessment of human
bronchial and lung epithelium revealed no major
difference between individuals with ALDH2 and ALDH2*2
genotypes
The human surgical samples assessed, included 26 lung
and 23 bronchial samples. DNA was isolated from all
samples and genotyped for the ALDH2 polymorphism
(with ALDH2/ALDH2 alleles i.e. has functional ALDH2,
heterozygous ALDH2/ALDH2*2, or homozygous for the
ALDH2*2 allele i.e. with non-functional ALDH2). All
human samples examined were either ALDH2/ALDH2
or ALDH2/ALDH2*2 heterozygous and no ALDH2*2
homozygous samples. Fixed and embedded bronchial
portions were histologically assessed for epithelial abnor-
malities. Of 13 bronchial samples with the ALDH2
alleles, three samples showed goblet cell hyperplasia. Of
10 ALDH2/ALDH2*2 heterozygous bronchial samples,
two showed basal cell hyperplasia, one showed goblet
cell hyperplasia, and one showed both goblet and basal
cell hyperplasia (Fig. 1a-f ). Smoking history was not
associated with hyperplasia development in both geno-
types. Then, to detect a potential functional impairment
on stem cells, both bronchial and lung epithelial stem
cells were examined using the in vitro 3D colony
forming assay [9, 10]. The CFE of primary and passaged
epithelial cells of ALDH2/ALDH2 and ALDH2/ALDH2*2
heterozygous bronchial and lung samples was compared
(Fig. 1g-l). The average primary bronchial CFE from 8
ALDH2/ALDH2 samples was 2.33%, while that from 5
ALDH2/ALDH2*2 heterozygous samples was only 1.58%
(Fig. 1m). When the colonies were passaged to examine
clonality, CFE at passage 1 in 6 ALDH2/ALDH2 samples
was 0.86%, and that in 4 ALDH2/ALDH2*2 heterozygous
samples was 0.56% (Fig. 1n). The primary lung CFE in
11 ALDH2/ALDH2 samples was 0.3%, and that in 6
ALDH2/ALDH2*2 heterozygous samples was 0.12%
(Fig. 1o). Although the average CFE of both bronchial
and lung samples in samples with the ALDH2 genotype
tended to be higher than that with the ALDH2*2 geno-
type, the difference was not statistically significant.
ALDH2 activation using a small molecule activator,
Alda-1 [25], successfully increased the CFE of both
bronchial and lung ALDH2/ALDH2*2 heterozygous epi-
thelium by approximately 50% and 34% of their original
efficiency, respectively. However, Alda-1 treatment of
ALDH2/ALDH2 bronchial and lung epithelium pro-
duced a similar respective induction of 51% and 32.5%
(Fig. 1k, l, p, q). Analysis of the differentiation profile of
bronchial and lung colonies from both genotypes re-
vealed no difference.
Loss of ALDH2 function is associated with downregulation
of antioxidant genes in the human lungs, but no effect was
detected on other ALDHs
To examine if the absence of ALDH2 activity in the
lungs results in compensatory upregulation or downreg-
ulation, or shows no effect on other functionally relevant
genes, we examined the expression of other lung-
expressed ALDHs and antioxidant genes in all human
samples and analyzed their levels in individuals with
ALDH2/ALDH2 versus ALDH2/ALDH2*2 heterozygous
genotypes using RT-PCR. The expression of antioxidant
genes, NRF2 and PRDX1, were significantly lower in the
ALDH2/ALDH2*2 heterozygous than in the ALDH2/
ALDH2 (Fig. 2a-d). HMOX-1 showed a trend towards
lower expression but the difference was not significant
(Fig. 2e, f). ALDH1A1 and ALDH3A1, and the antioxidants,
NQO1 and TXNRD1, showed no significant difference.
ALDH1A1 and ALDH3A1 expression was confirmed at
the protein level using western blotting. The expression of
these proteins varied among samples and no significant dif-
ference was observed between the ALDH2/ALDH2 and
ALDH2/ALDH2*2 heterozygous samples (data not shown).
Tracheas of adult mice with disturbed Aldh2 function
display fewer basal cells and lower epithelial cellular
density than those of WT mice
To further characterize the effect of the ALDH2 loss-of-
function polymorphism on lung epithelial development,
stem cell function, and repair after injury, we used two
different types of mice with disturbed Aldh2 function.
An Aldh2−/− mouse, which expresses no Aldh2 protein
[28] and an Aldh2*2 Tg mouse, which possesses an in-
tact endogenous Aldh2, but overexpresses the Aldh2*2
(mutant) gene and protein. This non-functional protein
interferes with the functions of the endogenous Aldh2 in
a “dominant negative effect”, mimicking the effect of the
human ALDH2 polymorphism [27]. We histologically
compared the naïve mouse tracheas among WT,
Aldh2*2 Tg, and Aldh2−/− mice at birth, adult, and old
age (Fig. 3a-i). Interestingly, significant differences in the
tracheal epithelia were observed only in adult mice, but
not in the newborn or old aged mice. The tracheal epi-
thelia were thinner and showed lower cellular density in
Aldh2*2 Tg and Aldh2−/− mice than in WT mice
(Fig. 3d-f, quantified in m-n).
When the cellular subtypes of adult tracheas from
all groups were analyzed to explain the decrease in
epithelial thickness and cellular density in Aldh2*2 Tg
and Aldh2−/− mice, only the basal, but not the club
or ciliated cells, showed a significantly lower ratio in
Aldh2*2 Tg and Aldh2−/− mice than in WT mice
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(Fig. 3j-l, quantified in o). The decrease in the basal cell
ratio was compensated for by an increase in ciliated and
unidentified (intermediate/undetermined) cells, but not by
the club cells. Basal cells are the stem cells in mouse tra-
chea, capable of both self-renewal and differentiation into
club and ciliated cells; the role of the unidentified (inter-
mediate/undetermined) cells is not well understood [33].
These findings suggest that Aldh2 is involved in regulating
the self-renewal and differentiation of basal stem cells in
vivo. On the other hand, histological examination of the
lung parenchyma and intra-pulmonary airways from all
the adult mouse groups showed no significant difference
compared to those of WT mice (Fig. 3p-r). Intrapulmon-
ary airways, which contain no basal cells and are lined
Fig. 1 Histology and in vitro CFE of human samples with the ALDH2/ALDH2 or ALDH2/ALDH2*2 heterozygous alleles. Bronchial sections from all
individuals were stained with H&E and were immunostained for basal, goblet, and ciliated cell markers using antibodies against K5, MUC5AC, and
β-tubulin, respectively. a-f show representative images for: normal epithelial lining (a, b) goblet cell hyperplasia c, d and basal cell hyperplasia
(e, f). Bronchial and lung epithelial cells isolated from ALDH2/ALDH2 and ALDH2/ALDH2*2 heterozygous samples were cultured in the in vitro
3D- stem cell colony forming assay. Representative images are shown for the bronchial colonies (g, h) and lung colonies (i, j) from the ALDH2/
ALDH2 and ALDH2/ALDH2*2 heterozygous samples, respectively. k, l show representative images for the inducing effect of ALDH2 activation
by Alda-1 treatment on the bronchial CFE (compare to g and h). CFE of the primary and clonally passaged cells were calculated for all the samples
examined (m-o). The effect of ALDH2 activation on CFE was calculated for each sample from parallel-treated culture wells. The percentage of increase
in CFE in comparison to the untreated wells is shown (p, q). ALDH2: ALDH2/ALDH2, ALDH2*2: ALDH2/ALDH2*2, Bron: bronchial, Col: colonies. Scale bars:
(a-f) 20 μm; (g-l) 500 μm. b, d, and f: Nuclei were stained with DAPI (blue)
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mainly with club cells and ciliated cells, were immuno-
stained and cellular subtypes were examined at the level
of proximal bronchi, mid-level bronchi, and terminal
bronchioles in all mice genotypes and no significant dif-
ferences were detected among them (Fig. 3s-u, quanti-
fied in v). The alveolar compartments showed no
abnormality as well.
Loss of Aldh2 results in marked increase in
morphologically abnormal mitochondria in basal and club
cells of mouse trachea
The relation between mitochondrial morphology and its
respiratory activity has been identified for a long time
[34]. Morphological differences between the mitochon-
dria of club cells and ciliated cells have been described
and are attributed to the high energy requirement of
ciliated cells, resulting in their mitochondria having
more cristae and a scanty matrix [35, 36]. In contrast,
pathological conditions like hypoxia or increased oxida-
tive stress result in “reduced-density” of the mitochondrial
matrix [37, 38]. As ALDH2 is a mitochondrial enzyme
whose deficiency augments oxidative stress [12, 13], we
examined the effect of its deficiency on the mitochondrial
morphology in airway epithelial cells, using TEM. In the
tracheas of WT adult mice, the previously described mor-
phological differences between the mitochondria in club
and ciliated cells were observed (i.e., fewer cristae and ex-
panded matrix in club cells) [35, 36]. In this study, we de-
tected the presence of a previously unknown minor
population of “abnormal” mitochondria, which showed
near complete lack of cristae and a marked decrease in
matrix density in all groups (Fig. 4a-b). We found these
abnormal mitochondria in the club cells and basal
cells, but not in ciliated cells (Fig. 4c). In most club
and basal cells of the WT trachea, these abnormal
mitochondria represented less than 20% of total mito-
chondria per cell. However, some cells had most of
their mitochondria showing this abnormal morpho-
logy. We quantified these abnormal mitochondria in a
large number of cells from all groups to identify
whether or not they were associated with the Aldh2
genotype. We set a threshold of 80% abnormal
mitochondria per cell to count a cell as a “cell with ab-
normal mitochondria”. Interestingly, we observed a
moderate increase in the percentage of these abnormal
mitochondria per cell in the club and basal cells of the
Aldh2*2 Tg and aged WT mice, but this increase was
not as high as our set threshold of 80%. Surprisingly,
many of the club and basal cells in Aldh2−/− mice
showed these abnormal mitochondria beyond the 80%
threshold and the number of these cells was strikingly
high (Fig. 4d) (Table 2).
Fig. 2 Effect of ALDH2 functional disturbance on the expression of antioxidant genes. RNA extracted from all human samples was examined to
determine the expression level of several antioxidant genes. Expression of NRF2 (a, b) and PRDX1 (c, d) was significantly higher in ALDH2/ALDH2
than in the ALDH2/ALDH2*2 heterozygous samples. HMOX-1 expression showed a similar trend but the differences were non-significant (e, f)
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Functional assessment of mitochondria in the tracheal
epithelium and in whole lung cells
The finding of a considerable number of morphologic-
ally abnormal mitochondria in the tracheal cells of
Aldh2−/− and, to a lesser extent, in Aldh2*2 Tg and WT
old mice prompted us to conduct several mitochondrial
functional assessments in these mice. We first assessed
the amount of mitochondria in the tracheal and lung
Fig. 3 Tracheal and lung histology of WT, Aldh2*2 Tg, and Aldh2−/− mice. (a-i) Trachea paraffin sections from WT, Aldh2*2 Tg, and Aldh2−/− mice
collected from newborn, adult, and aged mice were stained with H&E and examined for epithelial thickness and nuclear density, n = 4-6 mice/group.
Two-headed arrows show epithelial thickness (a-i). Similar tracheal sections were immunostained for basal (K5-green), club (Clara) (CC10-red), and
ciliated cell (β-tubulin-cyan) markers to quantify the tracheal cellular subtypes. Nuclei were stained with DAPI (blue) (j-l). Quantification of tracheal
surface epithelial thickness (m) and nuclear density (n) from all three groups. o Quantification for percentage of tracheal cellular types in all groups. UD:
Undetermined/Intermediate cells. *indicates significant P value compared to WT. Lung paraffin sections from adult WT, Aldh2*2 Tg, and Aldh2−/− mice
were stained with H&E and examined for airway and parenchymal abnormalities (p-r). Similar lung sections were immunostained for club (Clara)
(CC10-red) and ciliated cell (β-tubulin-green) markers to quantify the intrapumonary airway cellular subtypes. Nuclei were stained with DAPI (blue) (s-u).
v Quantification for intrapumonary airway percentages of club/ciliated cells in all mice groups. Scale bars: a-i: 25 μm, j-l: 50 μm
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cells in the different mouse strains by immunostaining
for the translocase of inner mitochondrial membrane,
Tim23. We then examined the quantity of “functional”
mitochondria using two different MitoTracker probes,
which stain only the functional mitochondria with active
membrane potential. Surprisingly, the tracheal and lung
cells in Aldh2−/− mice showed fewer mitochondria
(total and functional) than those in the WT, whereas
the Aldh2*2 Tg cells contained more mitochondria than
the WT (functional) (Fig. 5a-h). Secondly, we measured
mitochondrial ROS production using MitoSOX. Com-
pared to WT control, ROS level was higher in tracheal
epithelial cells from the Aldh2−/− mice, but not from
the Aldh2*2 Tg mice (Fig. 5i-j). Finally, we evaluated
the energy production efficiency by exploiting the
CellTiter-Glo Assay for measurement of ATP levels,
and by measuring the overall contribution of the two
major energy production pathways, the oxidative phos-
phorylation (mitochondrial respiration) pathway and
glycolysis, in cellular respiration using the extracellular
flux bioenergetics analyzer. No significant difference
was observed in the ATP levels of the tracheal or lung
cells among the groups (ATP levels in the Aldh2*2 Tg
and Aldh2−/− lungs were 90% and 103% and in their
MTEC were 97% and 94% of that in the cells of WT
mice, respectively). Comparing the OCR and ECAR in
WT and Aldh2−/− adult mice, MTECs showed no sig-
nificant difference (Fig. 5k-l).
Fig. 4 Detection of cells with a high number of morphologically abnormal mitochondria. Sections from WT, Aldh2*2 Tg, and Aldh2−/− adult mice
as well as from aged WT mice were examined with TEM for the presence of cellular ultrastructure abnormality. Compared to the typical shaped
normal mitochondria (a), morphologically abnormal mitochondria, with rounded shape, complete lack of cristae, and a marked decrease in matrix
density were detected in all groups (b). Some cells showed most mitochondria of the abnormal type (dotted arrows) and a few mitochondria of
the normal type (solid arrows) in club (dashed black line) and basal cells of all mice, but not in their ciliated cells (dotted white line) (c) (a, b, and
c are representative photos from WT). Aldh2−/− tracheas showed a large number of cells with >80% mitochondria being abnormal (dotted arrows)
(d). BM: Basement membrane
Table 2 Quantification of tracheal epithelial cells with abnormal
mitochondria
Basal cells Club cells Ciliated cells
WT 17% (n = 30) 14% (n = 66) 0% (n = 63)
WT (aged) 24% (n = 34) 11% (n = 61) 0% (n = 50)
Aldh2*2 Tg 19% (n = 31) 13% (n = 61) 0% (n = 53)
Aldh2−/− 88% (n = 41) 96% (n = 75) 14% (n = 65)
Percentage of cells with more than 80% of its mitochondria abnormal within a
cell type
(n = Number of cells examined per group)
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Assessment of tracheal basal stem cell function in the in
vitro 3D colony forming assay reveals no significant
difference between the WT, Aldh2*2 Tg, and Aldh2−/− mice
Next, we wanted to test whether the histological changes
observed in the tracheal basal cells and the abnormalities
in mitochondrial morphology and function that were de-
tected in the tracheal basal and club cells of the Aldh2*2
Tg and Aldh2−/− mice negatively influenced the ability of
basal cells to act as stem cells in vitro. We therefore iso-
lated MTECs from all groups and compared them using
the 3D stem cell colony forming assay [29]. Parallel cul-
ture wells were treated with vehicle, H2O2 (as a source
of ROS and oxidative stress), and/or the Aldh2 agonist,
Alda-1. ROS treatment resulted in CFE reduction, while
Alda-1 increased the CFE compared to that in the ve-
hicle- and the ROS-treated wells (Fig. 6a-f ). However, no
significant difference in CFE was detected among the
three groups of mice at the baseline or in response to
ROS and/or Alda-1 treatments (Fig. 6g). Because fi-
broblasts from individuals with the ALDH2*2 poly-
morphism are known to be more vulnerable to injury
than WT fibroblasts [39] and because fibroblasts are
an essential component of the lung stem cell niche
[29], we also investigated whether fibroblasts isolated
from the lungs of WT, Aldh2*2 Tg, and Aldh2−/− mice
have a different influence when co-cultured with WT
tracheal basal stem cells in the colony forming assay.
Co-culture with fibroblasts increased the CFE of WT
tracheal basal stem cells, but no significant difference
was observed among the three fibroblasts groups
(Fig. 6h-l). Analysis of the differentiation profile in the
grown colonies also revealed no significant difference.
Aldh2*2 Tg mice show resistance to emphysema
development in response to CS exposure compared to
WT mice
Because the disturbed Aldh2 function in our mouse
model revealed some functional effects on mitochondria,
but not on stem cells in naïve mice, we wanted to com-
pare them when they were exposed to some clinically-
relevant injuries. We exposed the mice to chronic injury
by CS, to acute injuries by H1N1 influenza viral infec-
tion, and to chemical injury using polidocanol.
Fig. 5 Functional and quantitative assessment of mitochondria in mouse tracheal and lung epithelium. MTECs and lung cells were collected from
WT, Aldh2*2 Tg, and Aldh2−/− mice, n = 4-5 mice/genotype. Cells were immunostained for the mitochondrial membrane protein, Tim23. No
difference in fluorescence intensity was observed between WT (a) and Aldh2*2 Tg (b), but MTECs from Aldh2−/− mice showed significantly lower
fluorescence intensity (c). Quantification of fluorescence intensity from multiple cells from each genotype is shown in (d). Cells were also stained
for MitoTracker (MT) probes and examined by fluorescence microscopy and flow cytometry. In comparison to WT cells (e), lung cells from Aldh2*2
Tg mice (f) had a higher fluorescence intensity, while the Aldh2−/− mice (g) showed lower fluorescence intensity. Quantification of fluorescence
intensity from multiple cells from each genotype is shown in (h). Not Aldh2*2 Tg (i) but Aldh2−/− (j) showed a higher level of mitochondrial ROS
than WT mice did. MTECs from WT and Aldh2−/− mice were examined using a flux analyzer to measure and compare OCR (k) and ECAR (l) as
indicators of the cellular mitochondrial respiration and glycolysis. No significant difference was observed between WT and Aldh2−/− cells. a-c, e-g
scale bars: 10 μm, nuclei were stained with DAPI (blue)
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Aldh2*2 Tg mice and their WT littermates were ex-
posed to CS for 16 weeks. Failure to gain weight com-
pared to sham smoked controls is an established sign of
the efficiency of the smoking protocol [40]. Indeed,
both mice groups did not gain weight over the 16 weeks
whereas the non-smoking control mice gained weight
(Fig. 7a). All lungs were examined by micro-CT
scanning followed by euthanasia and the lungs were
collected and embedded in paraffin, to examine for
digital and histological signs of lung damage and em-
physema. Digital readings of the low attenuation area
(LAA)%, CT values, and lung volumes were compared
between the WT and Aldh2*2 Tg mice as previously de-
scribed [31].
Fig. 6 In vitro MTEC CFE of WT, Aldh2*2 Tg, and Aldh2−/− mice. MTECs from all groups were collected and cultured in the 3D stem cell colony
forming assay (a-c) and parallel culture wells were treated with H2O2, and/or the Aldh2 agonist, Alda-1. Representative images of MTECs from WT
mice after treatments are shown in (d-f). Quantification of all wells from all groups is shown in (g). WT MTECs were cultured alone (h) or co-cultured
with lung fibroblasts isolated from WT, Aldh2*2 Tg, and Aldh2−/− mice (i-k). l Quantification of CFE from all co-culture wells
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Although no change was detected in LAA%, the lung
volume increased in WT mice (Fig. 7b) and mean linear
intercepts (Lm) showed a significant increase in WT
mice (Fig. 7c). These data suggest that mild emphysema
developed at 16 weeks of CS exposure in WT mice as
observed in the previous report [31]. On the other hand,
we found that CS exposure neither increased the lung
volume nor Lm in Aldh2*2 Tg mice (Fig. 7b-c) suggesting
that the Aldh2*2 Tg mice are resistant to emphysema de-
velopment in response to CS exposure.
As several mechanisms have been identified to mediate
the pathogenesis of CS-induced emphysema, we examined
several potential culprits. Mice without neutrophil elastase
or IL-1 receptor did not develop CS-induced emphysema
[41, 42] while mice with impaired expression of antioxi-
dant genes developed more severe emphysema [43]. We
used immunostaining to examine both naïve and CS-
exposed WT and Aldh2*2 Tg mice for neutrophil infiltra-
tion, IL-1β expression and expression of the anti-oxidant
Prdx1. In both WT and Aldh2*2 Tg mice, CS upregulated
IL-1β and increased the number of neutrophils in the
lungs. However, there were no significant differences
between WT and Aldh2*2 Tg mice before or after CS-
exposure (data not shown). Interestingly, naïve Aldh2*2
Tg showed higher expression of Prdx1, especially in air-
ways. However, CS similarly induced Prdx1 expression in
both WTand Aldh2*2 Tg mice (Fig. 7d-g).
Aldh2−/− mice sustain more extensive damage by
influenza virus infection compared to WT mice
WT and Aldh2−/− mice were infected with H1N1 in-
fluenza through the nose and lungs were collected
after 8 days. There was no difference in survival or
body weight loss. All lungs were examined histologi-
cally, and extensive inflammatory cell infiltration and
pneumonia were obvious in all mice with no signifi-
cant difference between the WT and Aldh2−/− (Fig. 8a-b).
However, when we quantified the epithelial cell types by
immunostaining, an average of only 70.6% of the lung area
in WT mice, but 80.6% in Aldh2−/− mice, showed complete
loss of AT-II cells (Fig. 8c-d). Similarly, loss of club cells in
the airways was more extensive in Aldh2−/− mice (58%)
than in WT mice (51.9%) (Fig. 8e-f). Viral load was con-
firmed using an immunostaining for hemagglutinin, a class
I viral fusion protein from the influenza virus’ envelope
proteins and we found no significant difference between
WTand Aldh2−/− mice (Fig. 8g-h).
WT, Aldh2*2 Tg, and Aldh2−/− mice show similar efficient
airway repair after polidocanol injury
We also optimized the polidocanol injury protocol as de-
scribed in the methods section. We found that adminis-
tration of 10 μL of 2% polidocanol using tracheal
intubation through a neck incision under anesthesia by
isoflurane inhalation with continuous O2 resulted in the
Fig. 7 Effect of chronic injury with cigarette smoke on Aldh2*2 Tg and WT mice. a Effect of 16 weeks of CS (or sham) exposure on body weight
(BW) of Aldh2*2 Tg mice and their WT littermates. b A representative graph showing the CT-calculated changes in lung volume versus CT-values
in the non-smoking and smoking groups. c A graph showing the mean linear intercept (Lm) quantification of all histological analyses from all
mice. NS: Non-smoking, S: smoking. d-g Representative immune fluorescence stained images showing that compared to naïve WT (d), naïve Tg
mice express higher Prdx1 (e). CS exposure upregulated Prdx1 expression in both WT (f) and Tg (g). d-g Scale bars: 50 μm. Prdx1-green, Nuclei
were stained with DAPI (blue) (d-g)
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best survival and consistency. We administered polido-
canol to the WT, Aldh2*2 Tg, and Aldh2−/− mice, and
then collected samples at 12 h, 24 h, 48 h, day 5, and
day 7 (n = 3–4/time point/genotype) for histological ana-
lysis. At 12 and 24 h, most epithelial cells had sloughed,
leaving only few basal cells attached to the basement
membrane (Fig. 9a-b). At 48 h, the surviving basal cells
were actively proliferating as indicated by their positive
staining for PCNA (proliferating cell nuclear antigen)
(Fig. 9c). At day 5 and more-clearly at day 7, the epithe-
lium was returning to the pseudo-stratified arrangement
with ciliated and club cells differentiating from the
proliferating basal cells (Fig. 9d-e). There was no signifi-
cant difference among the groups at any time points.
Although the Aldh2*2 Tg and Aldh2−/− mice had fewer
tracheal epithelial basal cells than the WT mice in the
steady state, the function of their basal cells in repairing
the epithelia after polidocanol injury was as efficient as
that in WT mice on day 7.
Discussion
In this study, we have examined the potential effects of
the common loss-of-function polymorphism in the hu-
man ALDH2 gene on the lungs. We found that human
Fig. 8 Effect of acute injury with H1N1 influenza infection on WT and Aldh2−/− mice. WT (n = 8) and Aldh2−/− (n = 7) mice were inoculated with
H1N1 virus and observed for 8 days. Representative H&E images from H1N1-infected mouse lungs showing extensive inflammatory cell infiltration
and pneumonia in both WT (a) and Aldh2−/− (b) lungs. Representative immune fluorescence stained images showing areas of damaged epithelial
cells in the lung parenchyma in WT (c) and Aldh2−/− (d) lungs. (note the presence of few alveolar type II cells, (SPC-green)). The damage is also
observed in the airway lining (note the reduced nuclear density, fewer club cells (CC10-red), and short ciliated cells (β-tubulin-cyan)) in WT (e)
and Aldh2−/− (f). Viral load comparison between WT (g) and Aldh2−/− (h) mice by staining for hemagglutinin (HA-green), showed no difference.
Scale bars: 50 μm. Nuclei were stained with DAPI (blue) (c-h)
Fig. 9 Effects of acute injury with polidocanol to tracheal epithelium of Aldh2*2 Tg, Aldh2−/−, and WT mice. a-b At 12 h after injury, most tracheal
epithelial cells slough off and only a few K5+ basal cells survived. c At 48 h, these surviving basal cells are positive for PCNA. d-e At day 7, near
complete repair is similarly observed in WT, Aldh2*2 Tg, and Aldh2−/− mice. The images shown are representative images from an Aldh2−/− mouse.
n = 3–4/time point/genotype, Scale bars: 50 μm. Nuclei were stained with DAPI (blue) (b, c, e)
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carriers of the loss-of-function ALDH2*2 allele presented
significantly lower FEV1/FVC than individuals who have
the ALDH2/ALDH2 allele, but that was not accompanied
with lower predicted FEV1%, faster rate of annual
FEV1 decline, or asthma/COPD. The mechanism
resulting in this isolated functional impairment re-
mains unclear. However, our results suggest that, in
addition to the ALDH2 loss of function, the presence
of several other genetic and environmental influences
is required to inflect a clinically observable obstructive
lung disease.
We expected that the lung cells might compensate for
lost ALDH2 function by upregulating other ALDHs and/
or antioxidants. However, surprisingly, NRF2, the key
transcription factor regulating antioxidant gene expression,
as well as one of the four antioxidant genes examined were
significantly lower in the ALDH2*2 human samples than in
the ALDH2 group, and no significant change was detected
in the expression of other ALDHs. Previous studies sug-
gested that the non-functional ALDH2*2 may inactivate
not only ALDH2, but also other structurally-similar
ALDHs by forming hetero-tetramers [27]. Our results
point to a previously unknown effect of the ALDH2 poly-
morphism, a negative effect on the antioxidant system.
In the mice experiments, we used two different types
of mice that have some basic differences, which might
explain some of the differences observed in their lung
phenotypes. Aldh2*2 Tg mice have smaller body size
compared to Aldh2−/− mice due to reduced muscle and
fat masses. This suggests that the phenotypes observable
in the Aldh2*2 Tg mice are not caused by the simple
lack of Aldh2 activity. It was suggested that the presence
of the non-functional Aldh2*2 enzyme in the cell inter-
feres with the ability of other Aldhs to detoxify alde-
hydes. Indeed, when the aldehyde reductase activity was
compared between these two mice, Aldh2−/− mouse dis-
played impaired Aldh activity only against acetaldehyde
(as expected) and hexanal, while the Aldh2*2 Tg mouse
showed impaired Aldh activity against most aldehydes
examined [27]. We detected a histological abnormality
in the tracheal epithelium in both Aldh2*2 Tg and
Aldh2−/− mice. Interestingly, these abnormalities (thin-
ning of the epithelium and decrease in cellular density
most probably due to decrease in the number of basal
cells) were not detectable at birth and only began to ap-
pear when the mice reached adulthood. Similar abnor-
malities (decrease in cellular density and basal cells)
were recently described in old WT mice as “age-related
changes” [44]. Indeed, our aged WT mice also showed
these age-related changes. Accordingly, the differences
in their tracheal cellular density and basal cell ratio in
comparison with those of old Aldh2*2 Tg and Aldh2−/−
mice became insignificant. This suggests that the Aldh2
loss-of-function polymorphism induced a kind of
accelerated aging in the airway epithelium. Similar
histological abnormality could not be identified in the
human samples, probably because of the small number
of samples examined and that all samples were from
aged individuals who have been exposed to multiple en-
vironmental confounding factors.
Another significant finding of this study is the detec-
tion of several abnormalities in the mitochondria of
Aldh2*2 Tg and Aldh2−/− mice. We detected a marked
increase in morphologically abnormal mitochondria in
the club and basal cells of Aldh2−/− mice and a moderate
increase in the Aldh2*2 Tg adult mice. The number of
these abnormal mitochondria was also moderately
higher in aged WT mice than in the adult WT mice,
again suggesting the premature appearance of aging-
related changes as a result of Aldh2 loss. Mitochondrial
function has long been recognized to decline during
aging, concomitant with the appearance of alterations in
mitochondrial morphology, e.g., abnormally rounded
mitochondria in aged mammals [45]. Therefore, on
finding the morphologically abnormal mitochondria, we
expected to also detect impairment of mitochondrial
function. Thus, it was not surprising that the Aldh2−/−
tracheal and lung cells presented fewer (functional)
mitochondria and higher mitochondrial ROS. However,
the finding that Aldh2*2 Tg mice have more mitochon-
dria than the WT mice and showed no increase in mito-
chondrial ROS was both surprising and intriguing. The
increase in the number of mitochondria and the upregu-
lation of the antioxidant Prdx1 in Aldh2*2 Tg mice
might also explain its resistance to CS-induced em-
physema compared to the WT mice. It is possible that
the lung cells in these mice developed some sort of
“tolerance” pathway to acclimatize to the absence of
Aldh2 function, similar to the pathway described in
the heart for cardioprotection against aldehydes [27].
Further intensive investigations are needed to explain
why the presence of non-functional Aldh2*2 in
Aldh2*2 Tg mice (but not the absence of Aldh2, as in
Aldh2−/− mice) results in such a differential effect on
mitochondria. This points to the fact that results ob-
tained from genetically engineered animals should not be
automatically extrapolated to humans because patho-
logical conditions in humans develop under the influence
of an enormous unknown genetic and environmental
variables.
To investigate a potential effect on stem cell function,
we examined both airway and distal lung epithelium of
both our mouse and human samples in our standardized
in vitro CFE. No significant differences were detected
among groups in mice or human, neither in the com-
parison of epithelial stem cells nor in their supportive
(niche) fibroblast cells. This is similar to what has been
described for the aging effect on mouse tracheal basal
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stem cells: despite the decrease in their number with
age, in vitro CFE is preserved [41].
Each injury model examined in this study showed a
different trend. Chronic exposure to CS resulted in
development of signs suggestive of emphysema in
WT, but not in Aldh2*2 Tg mice. The ALDH2*2 allele
is a risk factor for the development of many diseases
and cancers [16–19], especially when combined with
alcohol consumption. On the other hand, it provides
a protective effect against alcoholism and alcohol-
induced diseases, obviously by inducing a behavioral
change among individuals carrying the polymorphism
causing them to abstain from alcohol consumption to
avoid the unpleasant symptoms of flushing and severe
hangovers [46, 47]. However, a recent report sug-
gested that the ALDH2*2 allele provided an alcohol
consumption-independent protection against vascular
stenosis [48]. In this study, CS exposure increased the
lung volume in WT mice but not in Aldh2*2 Tg
mice. On the other hand, the CT value was increased
in Aldh2*2 Tg mice at 16 weeks. The same
phenomenon was temporarily observed in WT mice
until 12 weeks of CS, before development of emphy-
sema in our previous study [31]. These data imply
that the Aldh2*2 loss-of-function polymorphism pro-
tects against development of emphysema in response
to chronic CS. More experiments are needed to eluci-
date the exact role of ALDH2 in the development of
emphysema.
Further, there was no difference in the survival, body
weight loss, inflammatory cell infiltration, and pneu-
monia between the WT and Aldh2−/− mice infected
with H1N1 influenza virus. However, the Aldh2−/−
mice displayed a more extensive loss of airway and
lung parenchymal epithelium than the WT mice did.
A genetic association study on a large number of indi-
viduals with influenza infection is needed to compare
the severity of symptoms, the duration to recovery,
and extent of lung damage between the patients with
ALDH2 versus ALDH2*2 genotypes to confirm these
animal findings.
Finally, no difference in repair efficiency was observed
between the WT and the Aldh2*2 Tg or the Aldh2−/−
mice following polidocanol injury. Collectively, the
interaction and the role played by ALDH2 in the
lung cells seems complex and the outcome depends
on the cumulative interaction between the environ-
ment and the type of injuries/disease to which the
lungs are exposed throughout the lifetime of the in-
dividual. Future studies are warranted to elucidate
the interaction of ALDH2 enzyme and the environ-
mental insults specific to the lung, like air pollution
and CS, as well as ALDH2-specific insults associated
with alcohol consumption.
Conclusion
This is the first study to extensively characterize the
effects of the common human loss-of-function poly-
morphism in the ALDH2 gene on the lungs. We ana-
lyzed data from large human cohorts of healthy
individuals, patients with bronchial asthma and COPD,
as well as lung surgical samples. We also used two dif-
ferent models of genetically manipulated mice to mimic
the effect of the ALDH2 polymorphism in humans. We
conclude that the ALDH2 loss-of-function polymorphism
exerts several subtle effects on the lungs. Some of which
are similar to changes observed during normal aging of
the lungs.
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